|
Company:
|
FLUIDIGM CORP (FLDM)
|
|
Form Type:
|
SD
|
|
Filing Date:
|
5/28/2020
|
|
CIK:
|
0001162194
|
|
Address:
|
7000 SHORELINE COURT
SUITE 100
|
|
City, State, Zip:
|
SOUTH SAN FRANCISCO, California 94080
|
|
Telephone:
|
(650) 266-6000
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$6.18
|
Change:
0.21 (3.52%)
|
Trade Time:
Jan 15
|
Market Cap:
$458.06M
|
|
|
|
|
|
|
Description of Business
|
|
Fluidigm is a global company that improves life through comprehensive health
insight. Our innovative patented technologies and multi-omic tools are used by
researchers to reveal meaningful insights into health and disease, identify
biomarkers to inform decisions, and accelerate the development of more effective
therapies. We create, manufacture, and market a range of products and services,
including instruments, reagents and software that are used by researchers
worldwide.
Our focus is on the most pressing needs in translational and clinical research,
including cancer, immunology and immunotherapy. We use proprietary CyTOF® and
microfluidics technologies to develop innovative end-to-end solutions that have
the flexibility required to meet the needs of translational research and the
robustness to support high-impact clinical research studies.
Our mass cytometry Helios(TM) system deeply profiles cell phenotype and function.
|
|
|
|